Skip to main content
Premium Trial:

Request an Annual Quote

Geneart Posts 28 Percent Revenue Growth for 2008

NEW YORK (GenomeWeb News) – Geneart today released preliminary figures for its fiscal year 2008, showing a 28 percent jump in revenues to €15.7 million ($20.1 million) from €12.3 million.

The German gene synthesis firm had earnings before interest and taxes of €800,000, down from €1.8 million in 2007. It said that its profit was affected by one-time expenses associated with depreciations on inventories due to lower production costs and negative currency effects related to the US dollar.

In addition, Geneart cited a global shortage of the raw material acetonitrile, which it uses in its production process. The firm said it has had to "accept non-budgeted price increases" of the material.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.